Chemical Structure : BRD4 BD2 inhibitor ZX29
Catalog No.: PC-28677Not For Human Use, Lab Use Only.
BRD4 BD2 inhibitor ZX29 is a potent, BD2-selective BRD4 inhibitor with IC50 of 0.27 uM, SPR Kd of 1.68 uM, reduces cardiomyocyte death by inhibiting ferroptosis.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BRD4 BD2 inhibitor ZX29 is a potent, BD2-selective BRD4 inhibitor with IC50 of 0.27 uM, SPR Kd of 1.68 uM, reduces cardiomyocyte death by inhibiting ferroptosis.
ZX29 attenuates MI/RI and improves myocardial function in vivo.
ZX29 inhibits MI/RI-induced cardiac ferroptosis.
ZX29 inhibits the NCOA4-FTH1 pathway via BRD4 to attenuate cardiomyocyte ferroptosis.
ZX29 alleviates MI/RI-induced ferroptosis by inhibiting BRD4-YY1 interaction.
ZX29 preserves mitochondrial structural and functional homeostasis via BRD4 inhibition.
| M.Wt | 326.35 | |
| Formula | C19H18O5 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Zeyu Li, et al. Acta Pharm Sin B. 2026 Oct;16(10):6731-6755.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright